4 results match your criteria: "Complexo Universitario de Santiago de Compostela[Affiliation]"
Cancer Treat Res Commun
December 2022
Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
Background: In clinical studies, first-line afatinib demonstrated efficacy in Del19-EGFR NSCLC.
Materials And Methods: This prospective, non-interventional study assessed efficacy and safety of first-line afatinib in patients with advanced/metastatic NSCLC with Del19-EGFR from Galicia (Spain), with a preplanned analysis by age (<70 vs ≥70 years).
Results: Median age of 46 patients enrolled was 69.
Gastroenterol Hepatol
December 2018
Unidad de Enfermedad Inflamatoria Intestinal, Servicio de Aparato Digestivo, Complexo Universitario de Santiago de Compostela, Santiago de Compostela, España.
Gastroenterol Hepatol
February 2018
Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España.
Aims: To establish recommendations for the management of psychological problems affecting patients with inflammatory bowel disease (IBD).
Methods: A meeting of a group of IBD experts made up of doctors, psychologists, nurses and patient representatives was held. The following were presented: 1) Results of a previous focal group, 2) Results of doctor and patient surveys, 3) Results of a systematic review of tools for detecting anxiety and depression.
Inflamm Bowel Dis
September 2017
*Gastroenterology Department, Institute of Medical Research Gregorio Marañón (IiSGM); Hospital General Universitario Gregorio Marañón, Madrid, Spain; †Positivamente, Centro de Psicología, Madrid, Spain; ‡Confederation of Associations of Crohn's Disease and Ulcerative Colitis of Spain (ACCU), Madrid, Spain; §Inflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clínico San Carlos, Madrid, Spain; ‖Confederation of Associations of Crohn's Disease and Ulcerative Colitis of Spain (ACCU España), Madrid, Spain; ¶Merck Sharp & Dohme España, Madrid, Spain; **Inflammatory Bowel Disease Unit, Gastroenterology Department; Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; ††Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain; and ‡‡Inflammatory Bowel Disease Unit, Gastroenterology Department, Complexo Universitario de Santiago de Compostela, Santiago, Spain.
Background: To explore the perception of patients and gastroenterologists specialized in inflammatory bowel disease (IBD) on the impact of psychological factors on IBD course and its management.
Methods: Online surveys were sent to patients with IBD recruited from a national patient association and IBD specialists recruited from a national scientific society. These surveys were based on the results of a focus group and discussion group that explored the psychological aspects of IBD.